Paul Polman Archives - CDR – Chain Drug Review

Unilever’s Paul Polman to retire; Alan Jope named successor

November 29, 2018 by Chain Drug Review Alan Jope, Marijn Dekkers, Paul Polman, Unilever Business, Leading Headlines, Supplier News

LONDON — Unilever has announced that chief executive officer Paul Polman has decided to retire from the company. Alan Jope, currently president, beauty and personal care, has been appointed to the position, effective January 1, 2019, with Polman supporting the transition process during the first half of the year. Paul Polman has been Unilever CEO

Unilever set to acquire Murad

July 6, 2015 by Chain Drug Review and Chain Drug Review clinical skin care, Howard Murad, Murad, Paul Polman, Unilever Supplier News

LONDON and ROTTERDAM, Netherlands — Unilever has entered an agreement to buy clinical skin care brand Murad. The consumer products giant said the deal, terms of which weren’t disclosed, will bolster its position as a key player in the personal care prestige segment following other recent acquisitions, including Dermalogica, Kate Somerville and REN. Founded in